Long-term mental health resource utilization and cost of care following group psychoeducation or unstructured group support for bipolar disorders: A cost-benefit analysis

Journal of Clinical Psychiatry

Volumn 70, Issue 3, 2009, Pages 378-386

  Scott, Jan ^a   Colom, Francesc ^b   Popova, Ekaterina ^b   Benabarre, Antonio ^b   Cruz, Nuria ^b   Valenti, Marc ^b   Goikolea, José M ^b   Sánchez Moreno, Jose ^b   Asenjo, Miguel A ^c   Vieta, Eduard ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b HOSPITAL CLÍNIC   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; DIAZEPAM; FLUOXETINE; LAMOTRIGINE; LITHIUM; LITHIUM CARBONATE; LORAZEPAM; OLANZAPINE; QUETIAPINE; RISPERIDONE; VALPROIC ACID; VENLAFAXINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; NEUROLEPTIC AGENT; TRANQUILIZER;

ADULT; ARTICLE; BIPOLAR DISORDER; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DRUG USE; EMERGENCY CARE; FEMALE; FOLLOW UP; GROUP THERAPY; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITAL CARE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH SERVICE; OUTCOME ASSESSMENT; OUTPATIENT CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOEDUCATION; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; UNSTRUCTURED GROUP SUPPORT; COMPARATIVE STUDY; DRUG COST; ECONOMICS; HEALTH CARE PLANNING; HOSPITALIZATION; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATIENT EDUCATION; PUBLIC HEALTH; SPAIN; STATISTICS; UTILIZATION REVIEW;

ADULT; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; COMBINED MODALITY THERAPY; COST-BENEFIT ANALYSIS; DRUG COSTS; FEMALE; HEALTH CARE COSTS; HEALTH RESOURCES; HOSPITALIZATION; HUMANS; MALE; MENTAL HEALTH SERVICES; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; PATIENT EDUCATION AS TOPIC; PSYCHOTHERAPY, GROUP; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SINGLE-BLIND METHOD; SPAIN; UTILIZATION REVIEW; YOUNG ADULT;

EID: 64149122938     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.08m04333     Document Type: Article

References (25)

1. Murray C, Lopez A. The Global Burden of Disease: A Comprehensive Assessment of Morbidity and Disability from Diseases, Injuries and Risk Factors in 1990 and Projected to 2020. Cambridge, Mass: Harvard University Press; 1996
2. Wyatt RJ, Henter I. An economic evaluation of manic-depressive illness-1991. Soc Psychiatry Psychiatr Epidemiol 1995;30:213-219
3. Das GR, Guest JF. Annual cost of bipolar disorder to UK society. Br J Psychiatry 2002;180:227-233
4. Bryant-Comstock L, Stender M, Devercelli G. Health care utilization and costs among privately insured patients with bipolar I disorder. Bipolar Disord 2002;4:398-405 (Pubitemid 36041470)
5. Simon GE, Unutzer J. Health care utilization and costs among patients treated for bipolar disorder in an insured population. Psychiatr Serv 1999;50:1303-1308 (Pubitemid 29468533)
6. Frye MA, Calabrese JR, Reed ML, et al. Healthcare resource utilization in bipolar depression compared with unipolar depression: results of a United States population-based study. CNS Spectr 2006;11:704-710 (Pubitemid 44449655)
7. Scott J, Colom F. Psychosocial treatments for bipolar disorders. Psychiatr Clin North Am 2005;28:371-384 (Pubitemid 40501667)
8. Gianfrancesco F, Pesa J, Wang RH. Comparison of mental health resources used by patients with bipolar disorder treated with risperidone, olanzapine, or quetiapine. J Manag Care Pharm 2005;11:220-230
9. Calvert NW, Burch SP, Fu AZ, et al. The cost-effectiveness of lamotrigine in the maintenance treatment of adults with bipolar I disorder. J Manag Care Pharm 2006;12:322-330 (Pubitemid 47394447)
10. Scott J, Palmer S, Paykel E, et al. Use of cognitive therapy for relapse prevention in chronic depression: cost-effectiveness study. Br J Psychiatry 2003;182:221-227 (Pubitemid 36286735)
11. Kashner TM, Rush AJ, Crismon ML, et al. An empirical analysis of cost outcomes of the Texas Medication Algorithm Project. Psychiatr Serv 2006;57:648-659
12. Suppes T, Rush AJ, Dennehy EB, et al. Texas Medication Algorithm Project, phase 3 (TMAP-3): clinical results for patients with a history of mania. J Clin Psychiatry 2003;64:370-382 (Pubitemid 36547278)
13. Simon GE, Ludman EJ, Bauer MS, et al. Long-term effectiveness and cost of a systematic care program for bipolar disorder. Arch Gen Psychiatry 2006;63:500-508
14. Scott J, Colom F, Vieta E. A meta-analysis of relapse rates with adjunctive psychological therapies compared to usual psychiatric treatment for bipolar disorders. Int J Neuropsychopharmacol 2007;10:123-129 (Pubitemid 46122760)
15. Lam DH, McCrone P, Wright K, et al. Cost-effectiveness of relapse-prevention cognitive therapy for bipolar disorder: 30-month study. Br J Psychiatry 2005;186:500-506 (Pubitemid 40834870)
16. Bauer MS, McBride L, Williford WO, et al. Collaborative care for bipolar disorder, pt 2: impact on clinical outcome, function, and costs. Psychiatr Serv 2006;57:937-945 (Pubitemid 44036223)
17. Colom F, Vieta E, Martinez-Aran A, et al. A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission. Arch Gen Psychiatry 2003;60:402-407 (Pubitemid 36403001)
18. Colom F, Vieta E, Sánchez-Moreno J, et al. Group psychoeducation for stabilised bipolar patients: five-year outcome of a randomised clinical trial. Br J Psychiatry 2009;194:259-264
19. Colom F, Vieta E, Sánchez-Moreno J, et al. Stabilizing the stabilizer: group psychoeducation enhances the stability of serum lithium levels. Bipolar Disord 2005;7(suppl 5):32-36 (Pubitemid 43013458)
20. Scott J, Paykel E, Morriss R, et al. Cognitive-behavioural therapy for severe and recurrent bipolar disorders: randomised controlled trial. Br J Psychiatry 2006;188:313-320
21. Montoya A, Gilaberte I, Costi M, et al. [Bipolar disorder in Spain: functional status and resource use on the basis of the Spanish sample of the observational, Pan European EMBLEM study]. Vertex 2007;18(71):13-19
22. Stensland MD, Jacobson JG, Nyhuis A. Service utilization and associated direct costs for bipolar disorder in 2004: an analysis in managed care. J Affect Disord 2007;101:187-193
23. Stender M, Bryant-Comstock L, Phillips S. Medical resource use among patients treated for bipolar disorder: a retrospective, cross-sectional, descriptive analysis. Clin Ther 2002;24:1668-1676 (Pubitemid 35351851)
24. Davison A, Hinkley D. Bootstrap Methods and Their Applications. Cambridge, UK: Cambridge University Press; 1997
25. Chisholm D, van Ommeren M, Ayuso-Mateos JL, et al. Cost-effectiveness of clinical interventions for reducing the global burden of bipolar disorder. Br J Psychiatry 2005;187:559-567 (Pubitemid 41752746)